Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v11-FR
Language French French
Date Updated 2017-10-03 2017-09-05
Drug Identification Number 02292998 02292998
Brand name APO-CEFPROZIL APO-CEFPROZIL
Common or Proper name CEFPROZIL CEFPROZIL
Company Name APOTEX INC APOTEX INC
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-03-31 2016-03-31
Estimated end date 2017-12-15
Actual end date 2017-09-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments